How Optimism Can Close the Medicaid Coverage Gap

Low-income residents in states that haven’t expanded Medicaid are in a tough spot: They don’t qualify for the subsidies that people with slightly higher incomes get to buy marketplace plans because of a glitch in the federal health law. But a court decision last year makes it easier for them to make good-faith estimates of a pay increase, and there is no financial penalty if they don’t hit that figure.

Medicare Plan Finder Likely Won’t Note New $35 Cap on Out-of-Pocket Insulin Costs

In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.

Thousands of Experts Hired to Aid Public Health Departments Are Losing Their Jobs

As the covid-19 pandemic raged, an independent nonprofit tied to the Centers for Disease Control and Prevention hired an army of seasoned professionals to fill the gaps in the country’s public health system. Now, the money has largely run out, and state and local health departments are again without their expertise.

South Dakota Voters Approved Medicaid Expansion, but Implementation May Not Be Easy

South Dakotans voted to expand the state’s Medicaid program to cover thousands of additional low-income residents. But as other conservative states have shown, voter approval doesn’t always mean politicians and administrators will rush to implement the change.

Abortion Issue Helps Limit Democrats’ Losses in Midterms

Although control of Congress was still undecided Wednesday, Republicans seemed poised to take power in the House, while the fate of the Senate remained too close to call. Economic issues were at the top of voters’ minds, but abortion access also played a large role in their decisions.

Listen: With Abortion Rights on the Ballot in Michigan, Women Tell Their Stories

Women who need abortion care come to Michigan from surrounding states that already have banned the procedure. A clinic in suburban Detroit allowed a reporter to interview patients, doctors, and nurses to understand what is at stake as voters decide whether to guarantee abortion access in the Michigan Constitution.

Centene Showers Politicians With Millions as It Courts Contracts and Settles Overbilling Allegations

Centene, the largest Medicaid managed-care company in the U.S., has thrown more than $26.9 million at political campaigns across the country since 2015, especially focused on states where it is wooing Medicaid contracts and settling accusations that it overbilled taxpayers. Among its tactics: Centene is skirting contribution limits by giving to candidates through its many subsidiaries.

Hospital Investigated for Allegedly Denying an Emergency Abortion After Patient’s Water Broke

Federal officials have ordered the probe after reports that a woman whose water broke at 18 weeks could not get medical care recommended by her doctors to end the pregnancy because hospital officials were concerned about Missouri’s strict abortion law.

What Looks Like Pot, Acts Like Pot, but Is Legal Nearly Everywhere? Meet Hemp-Derived Delta-9 THC

The 2018 farm bill that legalized hemp created a loophole for an unregulated copycat of marijuana. A form of delta-9 THC — the psychoactive substance in pot — doesn’t face the same laws and regulations as marijuana because it comes from hemp. The drug is poised to upend the cannabis industry.

This Open Enrollment Season, Look Out for Health Insurance That Seems Too Good to Be True

Complaints about misleading health insurance marketing are soaring. State insurance commissioners are taking notice. They’ve created a shared internal database to monitor questionable business practices, and, in the future, they hope to provide a public-facing resource for consumers. In the meantime, consumers should shop wisely as open enrollment season begins.

$38,398 for a Single Shot of a Very Old Cancer Drug

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?

Drivers in Decline: A Shortage of Volunteers Complicates Access to Care in Rural America

Public transit is already insufficient in rural areas, leaving residents with few options as they travel greater distances to access health care. But older residents who depend on volunteer drivers to get them to appointments face another challenge: The number of those volunteers is declining.